Vaxcyte, Inc. Common Stock

PCVXNASDAQ • USD
61.61 USD
↘ 1.76 (2.78%)AT CLOSE (03:59 PM EST)
61.57
↘ 0.05 (0.07%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
61.57
↘ 0.05 (0.07%)
🔴Market: CLOSED

Shares of Vaxcyte, Inc. Common Stock (PCVX) are trading at $61.60. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. PCVX is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$63.37
High?$63.79
Low?$61.46
Prev. Close?$63.37
Volume?707.8K
Avg. Volume?3.2M
VWAP?$62.21
Rel. Volume?0.22x
Bid / Ask
Bid?$61.50 × 100
Ask?$67.93 × 100
Spread?$6.43
Midpoint?$64.72
Valuation & Ratios
Market Cap?10.0B
Shares Out?158.3M
Float?130.6M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?4.03
EPS?-$7.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
Employees
507
Market Cap
10.0B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2020-06-12
Address
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS, CA 94070
Phone: 650-837-0111
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
29
Piotroski F-Score?0/9Weak
Altman Z-Score?9.67Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.76%High
Short Interest?15.4M
Days to Cover?6.7
Free Float130.6M
Avg Daily Volume2.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.56Strong
Quick Ratio?4.56Strong
Cash Ratio?0.42Low
Debt/Equity?0.04Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
44
4.03FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-46.1%WEAK▾
ROA?
S&P
3
-38.4%WEAK▾
Cash Flow & Enterprise
FCF?$-994759000
Enterprise Value?$10.0B
Fundamentals ratios updated end of day